🇺🇸 FDA
Patent

US 9889092

Low density lipoprotein nanocarriers for targeted delivery of omega-3 polyunsaturated fatty acids to cancer

granted A61KA61K31/202A61K45/06

Quick answer

US patent 9889092 (Low density lipoprotein nanocarriers for targeted delivery of omega-3 polyunsaturated fatty acids to cancer) held by The Board of Regents of the University of Texas System expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Feb 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/202, A61K45/06, A61K9/0019, A61K9/1275